Currently out of the existing stock ratings of Whit Mayo, 127 are a BUY (52.05%), 105 are a HOLD (43.03%), 12 are a SELL (4.92%).

Whit Mayo

Work Performance Price Targets & Ratings Chart

Analyst Whit Mayo, currently employed at LEERINK, carries an average stock price target met ratio of 77.31% that have a potential upside of 20.51% achieved within 173 days.

Whit Mayo’s has documented 499 price targets and ratings displayed on 34 stocks. The coverage is on Healthcare, Financial Services sectors.

Most recent stock forecast was given on ELV, Elevance Health at 18-Jul-2025.

Wall Street Analyst Whit Mayo

Analyst best performing recommendations are on EHAB (ENHABIT).
The best stock recommendation documented was for CLOV (CLOVER HEALTH INVESTMENTS CORP) at 11/8/2022. The price target of $1.5 was fulfilled within 3 days with a profit of $0.21 (16.28%) receiving and performance score of 54.26.

Average potential price target upside

of $95.94 (21.58%) on UNH (UNITEDHEALTH GROUP).
of $68.67 (17.65%) on HUM (HUMANA).
of $50.26 (27.38%) on HCA (HCA HOLDINGS).

ACHC Acadia Healthcare Company AHCO Adapthealth Corp AMED Amedisys ANTM Anthem APR Apria CI Cigna Corp HCA HCA Holdings HUM Humana THC Tenet Healthcare UNH UnitedHealth Group DVA DaVita HealthCare Partners LHCG LHC Group MD Mednax FMS Fresenius Medical Care SGRY Surgery Partners AGL agilon health CLOV Clover Health Investments Corp ONEM 1Life Healthcare OSH Oak Street Health PRVA Privia Health Group AIRS Airsculpt Technologies ELV Elevance Health UHS Universal Health Services BK Bank of New York Mellon EHC Encompass Health Corp MS Morgan Stanley BAC Bank of America Corp C Citigroup CMA Comerica FITB Fifth Third Bancorp RF Regions Financial EHAB Enhabit PNC PNC Financial Services Group ARDT Ardent Health Partners

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Andrew Mok (BARCLAYS)